Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26317513 | 0.84 | TSHR (0.43) | HRH2HRH1PIK3CDFAAHGPR119 | |
| SCHEMBL27979621 | 0.84 | — | — | |
| SCHEMBL15599233 | 0.83 | HRH2 (0.45) | HRH2HRH1PIK3CD | |
| SCHEMBL19400534 | 0.83 | HRH2 (0.42) | HRH2HRH1PIK3CDPLA2G7MGLL | |
| SCHEMBL770801 | 0.81 | HRH2 (0.41) | HRH2HRH1PIK3CDPLA2G7MGLL | |
| SCHEMBL15832599 | 0.80 | HRH2 (0.52) | HRH2HRH1PIK3CDPLA2G7MGLL | |
| SCHEMBL25567950 | 0.79 | HRH2 (0.45) | HRH2HRH1PIK3CDPLA2G7MGLL | |
| SCHEMBL7946318 | 0.79 | HRH2 (0.45) | HRH2HRH1PIK3CDGPR119SMN1; SMN2 | |
| SCHEMBL25963051 | 0.79 | HRH2 (0.40) | HRH2HRH1PIK3CDPLA2G7MGLL | |
| SCHEMBL24715746 | 0.79 | GPR119 (0.36) | HRH2HRH1FAAHGPR119SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230302142-A1 | Cytotoxic Agents | Pheon Therapeutics Ltd. (GB) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302142-A1 | Cytotoxic Agents | ANXA11, ANXA5, HAX1 | HRH2 2656/4885HRH1 2135/4885PIK3CD 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.